These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2525327)

  • 1. Effects of intravenous administration of nicorandil on cardiovascular hemodynamics and left ventricular function.
    Kambara H; Tamaki S; Nakamura Y; Kawai C
    Am J Cardiol; 1989 Jun; 63(21):56J-60J. PubMed ID: 2525327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of nicorandil on cardiovascular hemodynamics and left ventricular function.
    Kambara H; Nakamura Y; Tamaki S; Kawai C
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S104-8. PubMed ID: 2447416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of nicorandil (SG-75), a substance with nitro-properties and long-term effects in coronary patients: improvement of LV-function and wall motility without pacing-induced myocardial ischemia].
    Thormann J; Schlepper M; Kramer W; Gottwik M
    Z Kardiol; 1982 Nov; 71(11):747-53. PubMed ID: 6218703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of single-dose nicorandil in coronary artery disease.
    Coltart DJ; Signy M
    Am J Cardiol; 1989 Jun; 63(21):34J-39J. PubMed ID: 2525323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility.
    Baumbach A; Braun U; Döring G; Haase KK; Voelker W; Karsch KR
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():213-20. PubMed ID: 7647025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina.
    Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
    J Cardiovasc Pharmacol; 1983; 5(3):371-7. PubMed ID: 6191134
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
    Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH
    Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicorandil and cardiovascular performance in patients with coronary artery disease.
    Suryapranata H; MacLeod D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S45-51. PubMed ID: 1282175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs.
    Hashimoto K; Ohbayashi Y; Kinoshita M
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1449-54. PubMed ID: 2150492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of concomitant administration of isoflurane and nicorandil.
    Piriou V; Ross S; Pigott D; Evans R; Foex P
    Br J Anaesth; 1997 Jul; 79(1):68-77. PubMed ID: 9301392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction.
    Yokota M; Horisawa T; Iwase M; Miyahara T; Yoshida J; Kamihara S; Noda S; Tsunekawa A; Koide M; Tsuzuki M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S116-22. PubMed ID: 2447418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of nicorandil in coronary artery disease.
    Treese N; Erbel R; Meyer J
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S52-6. PubMed ID: 1282176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
    Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
    Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine.
    Lamping KA; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(1):158-66. PubMed ID: 2580137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
    Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of contractile function in post-ischaemic reperfused myocardium of conscious dogs: influence of nicorandil, a new antianginal agent.
    Shimshak TM; Preuss KC; Gross GJ; Brooks HL; Warltier DC
    Cardiovasc Res; 1986 Aug; 20(8):621-6. PubMed ID: 2947685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia.
    Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
    J Am Coll Cardiol; 1983 Aug; 2(2):332-7. PubMed ID: 6863766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular function.
    Remme WJ; Krauss XH; van Hoogenhuyze DC; Kruyssen DA
    J Am Coll Cardiol; 1993 Mar; 21(3):709-20. PubMed ID: 8436753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
    Kato K
    Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pacing-induced ischemia on early left ventricular filling and regional myocardial dynamics and their modification by nifedipine.
    Nakamura Y; Sasayama S; Nonogi H; Miyazaki S; Fujita M; Kihara Y; Konishi T; Kawai C
    Circulation; 1987 Dec; 76(6):1232-44. PubMed ID: 3677348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.